First FDA Clearance Issued for Myoelectric Prosthetic Control
From: Medical Design Technology - 05/03/2017
By: Megan Crouse

The Food and Drug Administration issued Class II medical device clearance to
Coapt, LLC for the Complete Control System, a myoelectric pattern recognition
system.

Coapt's Complete Control uses electrodes to intercept the electrical signals
sent from the user’s muscles to the missing limb. The prosthesis can then be
moved in a way that intuitively mimics the absent limb. In order to make the
prosthesis more comfortable for the user and easier to use, Complete Control
allows for electrode placement to be simplified so that less testing is
required in order to determine placement. The prosthesis can be controlled
using Complete Control without co-contractions or impulse switching, and it
is not limited by activation thresholds.

Read the entire article at:
https://www.mdtmag.com/news/2017/05/first-fda-clearance-issued-myoelectric-prosthetic-control

Links:
Coapt, LLC
http://www.coaptengineering.com

Complete Control (with video)
http://www.coaptengineering.com/technology.html

Coapt Pattern Recognition Compatible Devices
http://www.coaptengineering.com/uploads/1/0/5/1/105156115/coapt_compatible_devices_jan2017.pdf

Myoelectric Devices Meet Sensory-Motor Integration
https://www.mdtmag.com/news/2016/04/myoelectric-devices-meet-sensory-motor-integration

Major Gains Still to Be Made in Quality of Arm Prostheses
https://www.mdtmag.com/news/2017/02/major-gains-still-be-made-quality-arm-prostheses